252 related articles for article (PubMed ID: 11039902)
1. Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells.
Sheng Z; Sun W; Smith E; Cohen C; Sheng Z; Xu XX
Oncogene; 2000 Oct; 19(42):4847-54. PubMed ID: 11039902
[TBL] [Abstract][Full Text] [Related]
2. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis.
Capo-Chichi CD; Smith ER; Yang DH; Roland IH; Vanderveer L; Cohen C; Hamilton TC; Godwin AK; Xu XX
Cancer; 2002 Oct; 95(8):1802-15. PubMed ID: 12365030
[TBL] [Abstract][Full Text] [Related]
3. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.
Roland IH; Yang WL; Yang DH; Daly MB; Ozols RF; Hamilton TC; Lynch HT; Godwin AK; Xu XX
Cancer; 2003 Dec; 98(12):2607-23. PubMed ID: 14669280
[TBL] [Abstract][Full Text] [Related]
4. Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity.
Yang DH; Smith ER; Cohen C; Wu H; Patriotis C; Godwin AK; Hamilton TC; Xu XX
Cancer; 2002 May; 94(9):2380-92. PubMed ID: 12015763
[TBL] [Abstract][Full Text] [Related]
5. Disabled-2 inactivation is an early step in ovarian tumorigenicity.
Fazili Z; Sun W; Mittelstaedt S; Cohen C; Xu XX
Oncogene; 1999 May; 18(20):3104-13. PubMed ID: 10340382
[TBL] [Abstract][Full Text] [Related]
6. Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer.
Bagadi SA; Prasad CP; Srivastava A; Prashad R; Gupta SD; Ralhan R
Breast Cancer Res Treat; 2007 Sep; 104(3):277-86. PubMed ID: 17115114
[TBL] [Abstract][Full Text] [Related]
7. Structure, sequence, and promoter analysis of human disabled-2 gene (DAB2).
Sheng Z; He J; Tuppen JA; Sun W; Fazili Z; Smith ER; Dong FB; Xu XX
Genomics; 2000 Dec; 70(3):381-6. PubMed ID: 11161789
[TBL] [Abstract][Full Text] [Related]
8. Induction of disabled-2 gene during megakaryocyte differentiation of k562 cells.
Tseng CP; Huang CH; Tseng CC; Lin MH; Hsieh JT; Tseng CH
Biochem Biophys Res Commun; 2001 Jul; 285(1):129-35. PubMed ID: 11437382
[TBL] [Abstract][Full Text] [Related]
9. Hepatocytes maintain their function on basement membrane formed by epithelial cells.
Takashi H; Katsumi M; Toshihiro A
Biochem Biophys Res Commun; 2007 Jul; 359(1):151-6. PubMed ID: 17531195
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix.
Kruk PA; Uitto VJ; Firth JD; Dedhar S; Auersperg N
Exp Cell Res; 1994 Nov; 215(1):97-108. PubMed ID: 7525326
[TBL] [Abstract][Full Text] [Related]
11. Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor.
Zhou J; Hernandez G; Tu SW; Scholes J; Chen H; Tseng CP; Hsieh JT
Cancer Res; 2005 Jul; 65(14):6089-96. PubMed ID: 16024609
[TBL] [Abstract][Full Text] [Related]
12. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
[TBL] [Abstract][Full Text] [Related]
13. Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis.
Capo-chichi CD; Roland IH; Vanderveer L; Bao R; Yamagata T; Hirai H; Cohen C; Hamilton TC; Godwin AK; Xu XX
Cancer Res; 2003 Aug; 63(16):4967-77. PubMed ID: 12941822
[TBL] [Abstract][Full Text] [Related]
14. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
[TBL] [Abstract][Full Text] [Related]
15. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
[TBL] [Abstract][Full Text] [Related]
16. A laminin-rich basement membrane matrix influences estrogen receptor beta expression and morphology of MDA-MB-231 breast cancer cells.
Neubauer H; Ruoff A; Paessler N; Solomayer E; Wallwiener D; Fehm T
Oncol Rep; 2009 Feb; 21(2):475-81. PubMed ID: 19148525
[TBL] [Abstract][Full Text] [Related]
17. Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities.
Sommers CL; Thompson EW; Torri JA; Kemler R; Gelmann EP; Byers SW
Cell Growth Differ; 1991 Aug; 2(8):365-72. PubMed ID: 1793731
[TBL] [Abstract][Full Text] [Related]
18. Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway.
Bao JJ; Le XF; Wang RY; Yuan J; Wang L; Atkinson EN; LaPushin R; Andreeff M; Fang B; Yu Y; Bast RC
Cancer Res; 2002 Dec; 62(24):7264-72. PubMed ID: 12499268
[TBL] [Abstract][Full Text] [Related]
19. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
Jackson JG; Zhang X; Yoneda T; Yee D
Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
[TBL] [Abstract][Full Text] [Related]
20. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]